MDxHealth SA
MDXH
$2.04
$0.073.55%
NASDAQ
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.55M | 24.74M | 23.32M | 22.16M | 19.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.55M | 24.74M | 23.32M | 22.16M | 19.83M |
| Cost of Revenue | 10.86M | 9.22M | 9.04M | 8.87M | 7.77M |
| Gross Profit | 18.69M | 15.52M | 14.28M | 13.29M | 12.06M |
| SG&A Expenses | 19.63M | 15.57M | 16.35M | 16.48M | 15.39M |
| Depreciation & Amortization | 1.25M | 1.33M | 1.33M | 1.12M | 1.13M |
| Other Operating Expenses | -206.00K | 441.00K | -11.00K | -40.00K | -9.00K |
| Total Operating Expenses | 34.81M | 29.35M | 29.41M | 29.33M | 26.44M |
| Operating Income | -5.26M | -4.61M | -6.09M | -7.18M | -6.60M |
| Income Before Tax | -10.50M | -6.79M | -10.85M | -11.53M | -8.51M |
| Income Tax Expenses | -1.57M | 48.00K | 344.00K | -- | -- |
| Earnings from Continuing Operations | -8.93M | -6.84M | -11.19M | -11.53M | -8.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.93M | -6.84M | -11.19M | -11.53M | -8.51M |
| EBIT | -5.26M | -4.61M | -6.09M | -7.18M | -6.60M |
| EBITDA | -4.68M | -3.94M | -3.94M | -5.38M | -4.70M |
| EPS Basic | -0.17 | -0.14 | -0.40 | -0.42 | -0.31 |
| Normalized Basic EPS | -0.01 | 0.00 | -- | -0.16 | -- |
| EPS Diluted | -0.17 | -0.14 | -0.40 | -0.42 | -0.31 |
| Normalized Diluted EPS | -0.01 | 0.00 | -- | -0.16 | -- |
| Average Basic Shares Outstanding | 52.52M | 48.86M | 27.97M | 27.45M | 27.45M |
| Average Diluted Shares Outstanding | 52.52M | 48.86M | 27.97M | 27.45M | 27.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |